Concepedia

Michael L. Swain

ML

Statistics

Publications

6

Citations

227

H-Index

6

Active since

1975

Affiliations

AstraZeneca (United Kingdom)(Current)

Michael L. Swain is an author at AstraZeneca (United Kingdom) specializing in medicinal chemistry, heterocyclic chemistry, and heterocycle synthesis.

Publications per year

1975–2008

6

Publications

6

New classes of antibacterial oxazolidinones with C-5, methylene O-Linked heterocyclic side chains

Michael B. Gravestock, David Acton, Michael J Betts et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 59 citations

, , +16

Synthesis of and Novel Reactions with Bis[imidazol-2-yl]nitromethane

M. JOSEPH, Thomas Leigh, Michael L. Swain · Synthesis · 1977 · 48 citations

, , +5

The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing

Clifford D. Jones, David Andrews, Andrew Barker et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 42 citations · Full text

, , +14

Reactions of heterocycles with thiophosgene. Part IV. β,4-Dichloro-2-isothiocyanatocinnamaldehyde, a product from 4,7-Dichloroquinoline

Roy Hull, Patricia J. van den Broek, Michael L. Swain · Journal of the Chemical Society Perkin Transactions 1 · 1975 · 34 citations

, , +7

Reactions of heterocycles with thiophosgene. Part V. 7-Chloro-1,2-dihydro-4-methoxy-2-thioxoquinoline-3-carbaldehyde, a product from 7-chloro-4-methoxyquinoline

Roy Hull, Patricia J. van den Broek, Michael L. Swain · Journal of the Chemical Society Perkin Transactions 1 · 1975 · 24 citations

, , +9

1–5 of 6